Deep Creek Pharma, LLC
Yadkinville, NC · Biotech · Private
CF10, a DNA-based fluoropyrimidine polymer for colorectal cancer treatment
deepcreekpharma.com →- Grants
- $3.4M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Improved Treatment of Colorectal Cancer with CF10 | $396,429 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Improved Treatment of Colorectal Cancer with CF10 Diversity Supplement | $500,917 | |
| Federal grant | Department of Health and Human Services · Phase I · Improved Treatment of Colorectal Cancer with CF10 Diversity Supplement | $104,488 | |
| Federal grant | Department of Health and Human Services · Phase II · Improved Treatment of Colorectal Cancer with CF10 | $964,465 | |
| Federal grant | Department of Health and Human Services · Phase II · Improved Treatment of Colorectal Cancer with CF10 | $1,018,545 | |
| Federal grant | Department of Health and Human Services · Phase I · Modified Thrombin Binding Aptamer Treatment of CRC Metastasis | $399,968 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1672 | PELAGOS PHARMACEUTICALS, INC. | — | — |
| 1673 | Shire Pharmaceuticals | — | — |
| 1674 | PHOTOCHEM TECHNOLOGIES, LLC | — | — |
| 1675 | Deep Creek Pharma, LLC | — | — |
| 1676 | Cubist Pharmaceuticals | — | — |
| 1677 | Orphi Therapeutics Inc | — | — |
| 1678 | Myovant Sciences | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.